Advanced Human Imaging (ASX:AHI) - CEO and Chairman, Vlado Bosanac
CEO and Chairman, Vlado Bosanac
Source: AHI
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Advanced Human Imaging (AHI) enters the Estonian market after signing a binding term sheet with digital health provider Activate Health OÜ
  • Activate Health is an all-in-one solution for optimising health to expand the human lifespan with its platform including medical-grade health audits, targeted micro-programs, science-backed recommendations and on-demand coaching
  • Currently, it is building a digital therapeutics platform for the prevention and early intervention of metabolic syndrome
  • The term sheet will see Activate Health integrate AHI’s body scanning solution and comes after Activate conducting a successful trial of the AHI CompleteScan application
  • AHI is up 1.63 per cent on the market with shares trading at 62.5 cents

Advanced Human Imaging (AHI) has entered the Estonian market after signing a binding term sheet with digital health provider Activate Health OÜ.

Activate Health is an all-in-one solution for optimising health to expand the human lifespan.

Its platform features medical-grade health audits, targeted micro-programs, science-backed recommendations and on-demand coaching.

Currently, it is building a digital therapeutics platform for the prevention and early intervention of metabolic syndrome.

In January 2022, Activate Health was awarded a €1.05 million (A$1.66 million) grant from Enterprise Estonia to expand its digital health footprint.

“We are extremely excited to be working with AHI and to integrate their solution into the Activate platform application,” Activate Health Founder and CEO Siim Saare said.

“Furthermore, we are elated to have received a grant from Enterprise Estonia Applied Research Programme to further develop the Activate platform together with the Estonian Genome Centre, University of Tartu and SYNLAB.”

The term sheet will see Activate Health integrate AHI’s body scanning solution with all commercial agreements to be concluded within 30 days.

This follows Activate conducting a successful trial of the AHI CompleteScan application.

“Siim and his team have been great to work with and moved very quickly to consummate a term sheet with AHI once they had the opportunity to use the technology and see how well it performs,” AHI CEO Vlado Bosanac commented.

“The AHI MultiScan digital health solution will empower the Activate platform with the ability to identify chronic disease risk, for the early intervention, allowing Activate to intervene and assist their consumers with better health outcomes.”

AHI was up 1.63 per cent on the market with shares trading at 62.5 cents by the end of the trading day.

AHI by the numbers
More From The Market Online

Week 13 Wrap: Easter bunny delivers new all time high for ASX200

Another week, another all time high. The ASX200 clocked 7,901pts on Thursday for the first time…
The Market Online Video

Market Close: Green lights up on ASX for Easter hunt go

The ASX200 closed the day in record territory - nearly a per cent up with every…

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Market Update: ASX glows red hot with another hit record

The ASX200 is trading up, hitting a new high of 7901 point and eclipsing the last…